United Therapeutics (UTHR) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to 0.21%.
- United Therapeutics' Return on Capital Employed changed 0.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.21% for FY2024, which is 100.0% up from last year.
- As of Q3 2025, United Therapeutics' Return on Capital Employed stood at 0.21%, which was down 0.0% from 0.2% recorded in Q2 2025.
- Over the past 5 years, United Therapeutics' Return on Capital Employed peaked at 0.22% during Q2 2024, and registered a low of 0.08% during Q1 2021.
- Over the past 5 years, United Therapeutics' median Return on Capital Employed value was 0.18% (recorded in 2022), while the average stood at 0.17%.
- In the last 5 years, United Therapeutics' Return on Capital Employed tumbled by -900bps in 2021 and then skyrocketed by 1000bps in 2022.
- Quarter analysis of 5 years shows United Therapeutics' Return on Capital Employed stood at 0.12% in 2021, then soared by 52bps to 0.18% in 2022, then increased by 7bps to 0.19% in 2023, then rose by 12bps to 0.21% in 2024, then decreased by 0bps to 0.21% in 2025.
- Its last three reported values are 0.21% in Q3 2025, 0.2% for Q2 2025, and 0.21% during Q1 2025.